Clinical Trials

Showing trials with last updates posted in 2026.

NCT06479811 | RECRUITING | PHASE1
120 participants

[212Pb]VMT-Alpha-NET in Metastatic or Inoperable Somatostatin-Receptor Positive Gastrointestinal Neuroendocrine Tumors, Pheochromocytoma/Paragangliomas, Small Cell Lung, Renal Cell, and Head and Neck Cancers

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-18
Start Date:
2025-08-19
Completion:
2029-01-01
Conditions
  • Sinonasal Neuroendocrine Carcinoma
  • Nasopharyngeal Carcinoma
  • Esthesioneuroblastoma
  • Olfactory Neuroblastoma
  • Somatostatin Receptor Positive
  • Small Cell Lung Cancers
  • Pheochromocytoma/Paragangliomas
  • Kidney Cancers
  • Head and Neck Tumors
  • Gastrointestinal Neuroendocrine Tumors
Interventions
  • DRUG
No Results Yet
NCT06427798 | RECRUITING | PHASE1/PHASE2
66 participants

Somatostatin-Receptors (SSTR)-Agonist [212Pb]VMT-alpha-NET in Metastatic or Inoperable SSTR+ Gastrointestinal Neuroendocrine Tumor and Pheochromocytoma/Paraganglioma Previously Treated With Systemic Targeted Radioligand Therapy

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-18
Start Date:
2025-02-07
Completion:
2029-07-01
Conditions
  • Somatostatin Receptor Positive
  • Gastrointestinal Neuroendocrine Tumors
  • Pheochromocytoma
  • Paragangliomas
Interventions
  • DRUG
No Results Yet
NCT06416072 | ENROLLING_BY_INVITATION
3000 participants

Alzheimer's Plasma Extension

Study Type:
OBSERVATIONAL
Last Updated:
2026-08-18
Start Date:
2023-09-21
Completion:
2028-06-30
Conditions
  • Preclinical Alzheimer's Disease
  • Alzheimer's Disease (AD)
Interventions
  • RADIATION
No Results Yet
NCT06358859 | ACTIVE_NOT_RECRUITING | NA
300 participants

Delta GREENS Food is Medicine Intervention

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-18
Start Date:
2024-06-05
Completion:
2027-05-31
Conditions
  • Cardiometabolic Risk Factors
  • Diabetes
  • High Blood Pressure
  • Obesity
  • Nutrition Security
Interventions
  • OTHER
No Results Yet
NCT06239220 | RECRUITING | PHASE2
25 participants

PD-L1 t-haNK, NAI IL-15sa and Cetuximab for Recurrent, Metastatic HNSCC

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-18
Start Date:
2024-02-16
Completion:
2026-12-31
Conditions
  • Head and Neck Cancer
  • Head and Neck Squamous Cell Carcinoma
  • Metastatic Head and Neck Cancer
  • Recurrent Head and Neck Cancer
  • Metastatic Head-and-neck Squamous-cell Carcinoma
  • Recurrent Head and Neck Squamous Cell Carcinoma
Interventions
  • BIOLOGICAL
  • DRUG
No Results Yet
Previous
Sorted by latest updates
Next
Showing 40 trials per page